Advertisement

A New York City hospital specializing in cancer will be the first in that state to offer a thyroid cancer test being marketed by Genzyme Corp., owned by French drug maker Sanofi (NYSE: SNY), now that the test has been licensed by the state.

Advertisement
Advertisement